AYTU BIOPHARMA, INC (AYTU) Return on equity 2016–2025
AYTU BIOPHARMA, INC (AYTU) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-71.5%FY2025 · since FY2016: -279.4% → -71.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -71.5% | -14.3 pp |
| FY2024 | -57.2% | -13.8 pp |
| FY2023 | -43.3% | +202.2 pp |
| FY2022 | -245.5% | -203.1 pp |
| FY2021 | -42.4% | -28.0 pp |
| FY2020 | -14.3% | +368.5 pp |
| FY2019 | -382.8% | -306.9 pp |
| FY2018 | -75.9% | +486.8 pp |
| FY2017 | -562.7% | -283.3 pp |
| FY2016 | -279.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice